TXMD · All filings · Read this filing
What changed 10-Q
Item 5. Other Information
2025-05-13 compared with 2024-11-12 · 1 added, 2 removed, 21 unchanged (13% of the section changed)
1 unchanged sentence
Rule 10b5-1 Trading Plans
−Removed: During the three months ended September 30, 2024, none of the Company’s
+Added: During the three months ended March 31, 2025, none of the Company’s
directors or officers adopted or terminated any Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement (as such terms
10 unchanged sentences
the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
−Removed: November 12, 2024
TherapeuticsMD, Inc.
6 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.